Michael Sinclair, Director, 10% Owner at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 40,000 shares at $13.59 ($549K) on 2022-06-03, disclosed to the SEC on 2022-06-06.
Open-market sale of $549k OPNT by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.88 | 9,736 | $135K | 24.6% |
| 2 | $13.88 | 9,736 | $135K | 24.6% |
| 3 | $13.59 | 10,264 | $139K | 25.4% |
| 4 | $13.59 | 10,264 | $139K | 25.4% |
| Total | $13.73 avg | 40,000 | $549K | 100% |
| Filing → |
| OPNT | SELL | 2022-06-08 | $209K | — | Filing → |
| OPNT | SELL | 2021-08-25 | $3.6M | — | Filing → |
| OPNT | SELL | 2019-09-13 | $751K | — | Filing → |